Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Edison Liu, Andy Page

Premium

Edison Liu has been elected to the Foundation for the National Institutes of Health board of directors.

Liu is president and CEO of the Jackson Laboratory and president of the Human Genome Organization. He joined the Jackson Laboratory last year after serving as the founding executive director of the Genome Institute of Singapore. Prior to GIS, Liu was the scientific director of the National Cancer Institute's Division of Clinical Sciences.

BioArray News spoke with Liu when he was named CEO of the Jackson Laboratory last year (BAN 8/30/2011).


23andMe has named Andy Page to its board of directors.
Page currently serves as president of Gilt Group. Previously he served as chief operating and financial officer at PlayPhone; chief financial officer and senior vice president of business strategy at StubHub; and held senior executive positions at Panasas, ONI Systems, and Robertson Stephens & Company.

The Scan

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.

Study Tracks Outcomes in Children Born to Zika Virus-Infected Mothers

By following pregnancy outcomes for women with RT-PCR-confirmed Zika virus infections, researchers saw in Lancet Regional Health congenital abnormalities in roughly one-third of live-born children.

Team Presents Benchmark Study of RNA Classification Tools

With more than 135 transcriptomic datasets, researchers tested two dozen coding and non-coding RNA classification tools, establishing a set of potentially misclassified transcripts, as they report in Nucleic Acids Research.

Breast Cancer Risk Related to Pathogenic BRCA1 Mutation May Be Modified by Repeats

Several variable number tandem repeats appear to impact breast cancer risk and age at diagnosis in almost 350 individuals carrying a risky Ashkenazi Jewish BRCA1 founder mutation.